BioPACIFIC and Chemspeed Automated Polymer Synthesis

May 3, 2022
Featured Article

BioPACIFIC - UC Santa Barbara

The Robotic Polymer Synthesis Platform integrates robotic handling with an automated powder and liquid handler/dispenser and high-throughput characterization, enabling the characterization of monomers, polymers, and material properties on the same timescale with which they can be made, overcoming traditional challenges to high-throughput materials discovery. Additional features include temperature-controlled mixing stations with small scale reaction plates, photochemistry capability, and the option to conduct reactions under superheated conditions and pressure.

Read this inspiring arcticle:

Chemspeed Robotic Polymer Synthesis Platform

For more information about Chemspeed solutions:

ISYNTH

For details please contact [email protected]

Other Recent News

Discover more news articles you might be interested in

Read more about Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage
News Picture 1 1 V2
Featured
Jan
30

Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage

VDI news / nachrichten

Up to 220 paint samples per day go through a fully automated screening in a unique testing facility at Byk in Wesel. / Bis zu 220 Lackproben pro Tag durchlaufen ein vollautomatisches Screening in einer weltweit einmaligen Pruefanlage bei Byk in Wesel.

Read more about Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs
News Picture 1 1 V2
Featured
Jan
20

Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs

Selective hydrogenation plays a critical role in modern synthetic chemistry, particularly in the pharmaceutical industry, where the production of chiral molecules with high enantiomeric purity is essential for the efficacy and safety of active pharmaceutical ingredients (APIs). 

© Chemspeed Technologies 2026